Neuropeptide Research

Selank

Selank is a synthetic heptapeptide analogue of the immunopeptide tuftsin, studied as an anxiolytic and nootropic research compound. Supplied for laboratory research use only.

Read the full research profile
How it works · what studies report · scientific references
In stock
≥99% purity target · lot-tracked
Select size
Vial
Nasal spray
€30.00Vial
Ships from IrelandTracked, inside the EU
Dispatched in 1–2 working daysTracked, EU dispatch
Lost in transit?Replacement first
Real supportWhatsApp & email
Plain outer packaging, no product names or branding on the parcel. Questions? WhatsApp us
Secure guest checkout — pay by bank transfer, save 3% on eligible items.
Why does the vial look empty?
That’s normal. The peptide is supplied lyophilised (freeze-dried) — often a thin film or a few milligrams at the base of the vial, easy to mistake for empty. It’s all there; reconstitute with bacteriostatic water before use.
Research handling note
Reconstitute with bacteriostatic water and store the lyophilised vial at −20 °C until use; once reconstituted, refrigerate and use within the documented window. For laboratory research purposes only — not for human consumption, diagnostic, or therapeutic use. Need to work out your dilution? Use the reconstitution calculator
Neuropeptide Research

Selank — research profile

For research purposes only — not for human consumption

Selank is a synthetic analogue of the endogenous tetrapeptide tuftsin, developed at the Institute of Molecular Genetics in Russia. It is studied for calm-focus, anxiolytic-like and immunomodulatory activity without the sedation associated with classical anxiolytics.

Research models report effects on the balance of monoamine and GABAergic signalling, on brain-derived neurotrophic factor (BDNF) expression, and on the stability of endogenous enkephalins via inhibition of their degrading enzymes.

How it’s studied

  • Anxiolytic pathways: GABA-A and serotonergic balance in behavioural models.
  • Enkephalinase inhibition: stabilisation of endogenous regulatory peptides.
  • BDNF expression: neurotrophic signalling in the hippocampus.
  • Immunomodulation: tuftsin-linked immune signalling.

Areas under investigation

AreaReported research focus
Stress responseAnxiolytic-like activity without sedation in models.
CognitionAttention and memory pathways in research cohorts.
NeuroplasticityBDNF and monoamine modulation.

References

  1. Zozulya AA, et al. Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia. Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(4):38–48.

Specifications

SpecificationDetail
ProductSelank
FormatLyophilised vial or nasal spray
Fill5 mg
Molecular formulaC33H57N11O9
PuritySpecified to a 99%+ purity target — per-batch documentation will be published once independent lab testing completes
Price€30.00 (vial) · €35.00 (nasal spray)
AvailabilityIn stock — dispatched from Ireland within 1–2 working days, tracked
Supplied forLaboratory research use only — not for human consumption, diagnostic or therapeutic use
Verifiability

Batch Testing & COA

Every production batch is sent for independent, third-party analysis at Janoshik Analytical. When results return, the full Certificate of Analysis for the exact batch you receive is published here and in our COA library, carrying its SHA-256 checksum and the lot number printed on your vial, so you can confirm the document is genuine and untampered. We publish every certificate, including any that fail.

How to verify a COA and its SHA-256 checksum →

Insiders

First access: new batches, restocks and the lab tools.

Occasional, useful email: new-batch and restock notices, the free reconstitution calculator and guides, plus FIRST10 for 10% off your first order. No daily blasts.